Table 2 Clinical characterization of subject groups. FVC—forced vital capacity.
ALS patients | controls | p | |
|---|---|---|---|
m/f | 50/24 | 42/39 | 0.05 |
Age/years | 60 ± 13 median 62 range (22–81) | 60 ± 13 median 58 range (26–88) | 0.19 |
BMI/kg/m2 | 26 ± 4 median 24 range (15–32) | 24 ± 4 median 25 range (19–40) | 0.01 |
ALS-FRS-R | 37 ± 8 | – | – |
Slope (ALS-FRS-R)/year | − 10 ± 10 | – | – |
Disease duration/years | 2.1 ± 1.6 | – | – |
Onset (spinal/bulbar) | 50/14 | – | – |
FVC/% | 65 ± 14 | – | – |
Age at onset/years | 58 ± 12 | – | – |